APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Imaging Agent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Diagnostic Imaging Agent Market Analysis and Forecast 2026-2032

Report ID 173902880226 December 2025196 pages

Choose your research edition.

Industry ResearchDiagnostic Imaging Agent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Imaging Agent Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Diagnostic Imaging Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Imaging Agent Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Imaging Agent Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Diagnostic Imaging Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Diagnostic Imaging Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Diagnostic Imaging Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Diagnostic Imaging Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Diagnostic Imaging Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Diagnostic Imaging Agent include GE HealthCare, Bracco Diagnostic, Guerbet, Abx Advanced Biochemical, Bayer AG, Blue Earth Diagnostics, Cardinal Health, Eli Lilly and Company and Lantheus, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Diagnostic Imaging Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Diagnostic Imaging Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Diagnostic Imaging Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diagnostic Imaging Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diagnostic Imaging Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Diagnostic Imaging Agent sales, projected growth trends, production technology, application and end-user industry.

Diagnostic Imaging Agent Segment by Company

GE HealthCare

Bracco Diagnostic

Guerbet

Abx Advanced Biochemical

Bayer AG

Blue Earth Diagnostics

Cardinal Health

Eli Lilly and Company

Lantheus

Mallinckrodt

Navidea

Yantai Dongcheng

Foshan Rui Diao Pharmaceutical

Jubilant Pharma Limited

Diagnostic Imaging Agent Segment by Type

Conjugated Imaging Agent

Metabolic Imaging Agent

Blood Flow and Blood Volume Imaging Agents

Diagnostic Imaging Agent Segment by Application

Neurological Disease

Gastrointestinal Disease

Heart Disease

Tumor

Diagnostic Imaging Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Imaging Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Imaging Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Imaging Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Diagnostic Imaging Agent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Diagnostic Imaging Agent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Imaging Agent sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diagnostic Imaging Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Conjugated Imaging Agent Major Manufacturers Table 3. Metabolic Imaging Agent Major Manufacturers Table 4. Blood Flow and Blood Volume Imaging Agents Major Manufacturers Table 5. Global Diagnostic Imaging Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Neurological Disease Major Manufacturers Table 7. Gastrointestinal Disease Major Manufacturers Table 8. Heart Disease Major Manufacturers Table 9. Tumor Major Manufacturers Table 10. Diagnostic Imaging Agent Industry Trends Table 11. Diagnostic Imaging Agent Industry Drivers Table 12. Diagnostic Imaging Agent Industry Opportunities and Challenges Table 13. Diagnostic Imaging Agent Industry Restraints Table 14. Global Diagnostic Imaging Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Diagnostic Imaging Agent Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Diagnostic Imaging Agent Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Diagnostic Imaging Agent Revenue Market Share by Region (2021-2026) Table 18. Global Diagnostic Imaging Agent Revenue Market Share by Region (2027-2032) Table 19. Global Diagnostic Imaging Agent Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Diagnostic Imaging Agent Sales by Region (2021-2026) & (K Units) Table 21. Global Diagnostic Imaging Agent Sales by Region (2027-2032) & (K Units) Table 22. Global Diagnostic Imaging Agent Sales Market Share by Region (2021-2026) Table 23. Global Diagnostic Imaging Agent Sales Market Share by Region (2027-2032) Table 24. Global Diagnostic Imaging Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Diagnostic Imaging Agent Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Diagnostic Imaging Agent Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Diagnostic Imaging Agent Sales Market Share by Manufacturers (2021-2026) Table 28. Global Diagnostic Imaging Agent Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Diagnostic Imaging Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Diagnostic Imaging Agent Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Diagnostic Imaging Agent Manufacturers, Product Type & Application Table 32. Global Diagnostic Imaging Agent Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Diagnostic Imaging Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Diagnostic Imaging Agent Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Diagnostic Imaging Agent Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Diagnostic Imaging Agent Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Diagnostic Imaging Agent Revenue Market Share by Type (2021-2026) Table 39. Global Diagnostic Imaging Agent Revenue Market Share by Type (2027-2032) Table 40. Global Diagnostic Imaging Agent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 42. Global Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 43. Global Diagnostic Imaging Agent Sales Market Share by Type (2021-2026) Table 44. Global Diagnostic Imaging Agent Sales Market Share by Type (2027-2032) Table 45. Global Diagnostic Imaging Agent Price by Type (2021-2026) & (US$/Unit) Table 46. Global Diagnostic Imaging Agent Price by Type (2027-2032) & (US$/Unit) Table 47. Global Diagnostic Imaging Agent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Diagnostic Imaging Agent Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Diagnostic Imaging Agent Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Diagnostic Imaging Agent Revenue Market Share by Application (2021-2026) Table 51. Global Diagnostic Imaging Agent Revenue Market Share by Application (2027-2032) Table 52. Global Diagnostic Imaging Agent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 54. Global Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 55. Global Diagnostic Imaging Agent Sales Market Share by Application (2021-2026) Table 56. Global Diagnostic Imaging Agent Sales Market Share by Application (2027-2032) Table 57. Global Diagnostic Imaging Agent Price by Application (2021-2026) & (US$/Unit) Table 58. Global Diagnostic Imaging Agent Price by Application (2027-2032) & (US$/Unit) Table 59. GE HealthCare Company Information Table 60. GE HealthCare Business Overview Table 61. GE HealthCare Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. GE HealthCare Diagnostic Imaging Agent Product Portfolio Table 63. GE HealthCare Recent Development Table 64. Bracco Diagnostic Company Information Table 65. Bracco Diagnostic Business Overview Table 66. Bracco Diagnostic Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio Table 68. Bracco Diagnostic Recent Development Table 69. Guerbet Company Information Table 70. Guerbet Business Overview Table 71. Guerbet Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Guerbet Diagnostic Imaging Agent Product Portfolio Table 73. Guerbet Recent Development Table 74. Abx Advanced Biochemical Company Information Table 75. Abx Advanced Biochemical Business Overview Table 76. Abx Advanced Biochemical Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio Table 78. Abx Advanced Biochemical Recent Development Table 79. Bayer AG Company Information Table 80. Bayer AG Business Overview Table 81. Bayer AG Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bayer AG Diagnostic Imaging Agent Product Portfolio Table 83. Bayer AG Recent Development Table 84. Blue Earth Diagnostics Company Information Table 85. Blue Earth Diagnostics Business Overview Table 86. Blue Earth Diagnostics Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio Table 88. Blue Earth Diagnostics Recent Development Table 89. Cardinal Health Company Information Table 90. Cardinal Health Business Overview Table 91. Cardinal Health Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Cardinal Health Diagnostic Imaging Agent Product Portfolio Table 93. Cardinal Health Recent Development Table 94. Eli Lilly and Company Company Information Table 95. Eli Lilly and Company Business Overview Table 96. Eli Lilly and Company Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio Table 98. Eli Lilly and Company Recent Development Table 99. Lantheus Company Information Table 100. Lantheus Business Overview Table 101. Lantheus Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lantheus Diagnostic Imaging Agent Product Portfolio Table 103. Lantheus Recent Development Table 104. Mallinckrodt Company Information Table 105. Mallinckrodt Business Overview Table 106. Mallinckrodt Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Mallinckrodt Diagnostic Imaging Agent Product Portfolio Table 108. Mallinckrodt Recent Development Table 109. Navidea Company Information Table 110. Navidea Business Overview Table 111. Navidea Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Navidea Diagnostic Imaging Agent Product Portfolio Table 113. Navidea Recent Development Table 114. Yantai Dongcheng Company Information Table 115. Yantai Dongcheng Business Overview Table 116. Yantai Dongcheng Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio Table 118. Yantai Dongcheng Recent Development Table 119. Foshan Rui Diao Pharmaceutical Company Information Table 120. Foshan Rui Diao Pharmaceutical Business Overview Table 121. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio Table 123. Foshan Rui Diao Pharmaceutical Recent Development Table 124. Jubilant Pharma Limited Company Information Table 125. Jubilant Pharma Limited Business Overview Table 126. Jubilant Pharma Limited Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio Table 128. Jubilant Pharma Limited Recent Development Table 129. North America Diagnostic Imaging Agent Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Diagnostic Imaging Agent Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 132. North America Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 133. North America Diagnostic Imaging Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 134. North America Diagnostic Imaging Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 135. North America Diagnostic Imaging Agent Revenue by Application (2021-2026) & (US$ Million) Table 136. North America Diagnostic Imaging Agent Revenue by Application (2027-2032) & (US$ Million) Table 137. North America Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 138. North America Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 139. North America Diagnostic Imaging Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 140. North America Diagnostic Imaging Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 141. North America Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Diagnostic Imaging Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. North America Diagnostic Imaging Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. North America Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. North America Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 146. North America Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 147. North America Diagnostic Imaging Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 148. North America Diagnostic Imaging Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 149. United States Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 150. Canada Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 151. Mexico Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 152. Europe Diagnostic Imaging Agent Revenue by Type (2021-2026) & (US$ Million) Table 153. Europe Diagnostic Imaging Agent Revenue by Type (2027-2032) & (US$ Million) Table 154. Europe Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 155. Europe Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 156. Europe Diagnostic Imaging Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Europe Diagnostic Imaging Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Europe Diagnostic Imaging Agent Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Diagnostic Imaging Agent Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 161. Europe Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 162. Europe Diagnostic Imaging Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Europe Diagnostic Imaging Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Europe Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Europe Diagnostic Imaging Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Europe Diagnostic Imaging Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Europe Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Europe Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 169. Europe Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 170. Europe Diagnostic Imaging Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Europe Diagnostic Imaging Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Germany Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 173. France Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 174. U.K. Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 175. Italy Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 176. Russia Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 177. Spain Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 178. Netherlands Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 179. Switzerland Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 180. Sweden Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 181. Poland Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 182. China Diagnostic Imaging Agent Revenue by Type (2021-2026) & (US$ Million) Table 183. China Diagnostic Imaging Agent Revenue by Type (2027-2032) & (US$ Million) Table 184. China Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 185. China Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 186. China Diagnostic Imaging Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 187. China Diagnostic Imaging Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 188. China Diagnostic Imaging Agent Revenue by Application (2021-2026) & (US$ Million) Table 189. China Diagnostic Imaging Agent Revenue by Application (2027-2032) & (US$ Million) Table 190. China Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 191. China Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 192. China Diagnostic Imaging Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 193. China Diagnostic Imaging Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Diagnostic Imaging Agent Revenue by Type (2021-2026) & (US$ Million) Table 195. Asia Diagnostic Imaging Agent Revenue by Type (2027-2032) & (US$ Million) Table 196. Asia Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 197. Asia Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 198. Asia Diagnostic Imaging Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 199. Asia Diagnostic Imaging Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 200. Asia Diagnostic Imaging Agent Revenue by Application (2021-2026) & (US$ Million) Table 201. Asia Diagnostic Imaging Agent Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 203. Asia Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 204. Asia Diagnostic Imaging Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 205. Asia Diagnostic Imaging Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Diagnostic Imaging Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Asia Diagnostic Imaging Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Asia Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. Asia Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 211. Asia Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 212. Asia Diagnostic Imaging Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 213. Asia Diagnostic Imaging Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Japan Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 215. South Korea Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 216. India Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 217. Australia Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 218. Taiwan Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 219. Southeast Asia Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 220. SAMEA Diagnostic Imaging Agent Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Diagnostic Imaging Agent Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 223. SAMEA Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 224. SAMEA Diagnostic Imaging Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 225. SAMEA Diagnostic Imaging Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 226. SAMEA Diagnostic Imaging Agent Revenue by Application (2021-2026) & (US$ Million) Table 227. SAMEA Diagnostic Imaging Agent Revenue by Application (2027-2032) & (US$ Million) Table 228. SAMEA Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 229. SAMEA Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 230. SAMEA Diagnostic Imaging Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 231. SAMEA Diagnostic Imaging Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 232. SAMEA Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. SAMEA Diagnostic Imaging Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. SAMEA Diagnostic Imaging Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. SAMEA Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. SAMEA Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 237. SAMEA Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 238. SAMEA Diagnostic Imaging Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 239. SAMEA Diagnostic Imaging Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Brazil Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 241. Argentina Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 242. Chile Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 243. Colombia Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 244. Peru Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 245. Saudi Arabia Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 246. Israel Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 247. UAE Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 248. Turkey Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 249. Iran Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 250. Egypt Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Diagnostic Imaging Agent Distributors List Table 254. Diagnostic Imaging Agent Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Diagnostic Imaging Agent Image Figure 2. Global Diagnostic Imaging Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Imaging Agent Market Size Share 2021 VS 2025 VS 2032 Figure 4. Conjugated Imaging Agent Image Figure 5. Metabolic Imaging Agent Image Figure 6. Blood Flow and Blood Volume Imaging Agents Image Figure 7. Global Diagnostic Imaging Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Diagnostic Imaging Agent Market Size Share 2021 VS 2025 VS 2032 Figure 9. Neurological Disease Image Figure 10. Gastrointestinal Disease Image Figure 11. Heart Disease Image Figure 12. Tumor Image Figure 13. Global Diagnostic Imaging Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Figure 15. Global Diagnostic Imaging Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Diagnostic Imaging Agent Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Diagnostic Imaging Agent Revenue Market Share by Region (2021-2032) Figure 18. Global Diagnostic Imaging Agent Sales (2021-2032) & (K Units) Figure 19. Global Diagnostic Imaging Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Diagnostic Imaging Agent Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Diagnostic Imaging Agent Sales YoY (2021-2032) & (K Units) Figure 22. Europe Diagnostic Imaging Agent Sales YoY (2021-2032) & (K Units) Figure 23. China Diagnostic Imaging Agent Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Diagnostic Imaging Agent Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Diagnostic Imaging Agent Sales YoY (2021-2032) & (K Units) Figure 26. Global Diagnostic Imaging Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Diagnostic Imaging Agent Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Diagnostic Imaging Agent Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Diagnostic Imaging Agent Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Diagnostic Imaging Agent Revenue Market Share by Type (2021-2032) Figure 32. Global Diagnostic Imaging Agent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Diagnostic Imaging Agent Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Diagnostic Imaging Agent Sales Market Share by Type (2021-2032) Figure 35. Global Diagnostic Imaging Agent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Diagnostic Imaging Agent Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Diagnostic Imaging Agent Revenue Market Share by Application (2021-2032) Figure 38. Global Diagnostic Imaging Agent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Diagnostic Imaging Agent Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Diagnostic Imaging Agent Sales Market Share by Application (2021-2032) Figure 41. North America Diagnostic Imaging Agent Revenue Share by Type (2021-2032) Figure 42. North America Diagnostic Imaging Agent Sales Share by Type (2021-2032) Figure 43. North America Diagnostic Imaging Agent Revenue Share by Application (2021-2032) Figure 44. North America Diagnostic Imaging Agent Sales Share by Application (2021-2032) Figure 45. North America Diagnostic Imaging Agent Revenue Share by Country (2021-2032) Figure 46. North America Diagnostic Imaging Agent Sales Share by Country (2021-2032) Figure 47. Europe Diagnostic Imaging Agent Revenue Share by Type (2021-2032) Figure 48. Europe Diagnostic Imaging Agent Sales Share by Type (2021-2032) Figure 49. Europe Diagnostic Imaging Agent Revenue Share by Application (2021-2032) Figure 50. Europe Diagnostic Imaging Agent Sales Share by Application (2021-2032) Figure 51. Europe Diagnostic Imaging Agent Revenue Share by Country (2021-2032) Figure 52. Europe Diagnostic Imaging Agent Sales Share by Country (2021-2032) Figure 53. China Diagnostic Imaging Agent Revenue Share by Type (2021-2032) Figure 54. China Diagnostic Imaging Agent Sales Share by Type (2021-2032) Figure 55. China Diagnostic Imaging Agent Revenue Share by Application (2021-2032) Figure 56. China Diagnostic Imaging Agent Sales Share by Application (2021-2032) Figure 57. Asia Diagnostic Imaging Agent Revenue Share by Type (2021-2032) Figure 58. Asia Diagnostic Imaging Agent Sales Share by Type (2021-2032) Figure 59. Asia Diagnostic Imaging Agent Revenue Share by Application (2021-2032) Figure 60. Asia Diagnostic Imaging Agent Sales Share by Application (2021-2032) Figure 61. Asia Diagnostic Imaging Agent Revenue Share by Country (2021-2032) Figure 62. Asia Diagnostic Imaging Agent Sales Share by Country (2021-2032) Figure 63. SAMEA Diagnostic Imaging Agent Revenue Share by Type (2021-2032) Figure 64. SAMEA Diagnostic Imaging Agent Sales Share by Type (2021-2032) Figure 65. SAMEA Diagnostic Imaging Agent Revenue Share by Application (2021-2032) Figure 66. SAMEA Diagnostic Imaging Agent Sales Share by Application (2021-2032) Figure 67. SAMEA Diagnostic Imaging Agent Revenue Share by Country (2021-2032) Figure 68. SAMEA Diagnostic Imaging Agent Sales Share by Country (2021-2032) Figure 69. Diagnostic Imaging Agent Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Diagnostic Imaging Agent Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Conjugated Imaging Agent
  • Metabolic Imaging Agent
  • Blood Flow and Blood Volume Imaging Agents
Applications
  • Neurological Disease
  • Gastrointestinal Disease
  • Heart Disease
  • Tumor
Companies covered
  • GE HealthCare
  • Bracco Diagnostic
  • Guerbet
  • Abx Advanced Biochemical
  • Bayer AG
  • Blue Earth Diagnostics
  • Cardinal Health
  • Eli Lilly and Company
  • Lantheus
  • Mallinckrodt
  • Navidea
  • Yantai Dongcheng
  • Foshan Rui Diao Pharmaceutical
  • Jubilant Pharma Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Diagnostic Imaging Agent Market by Type
  3. 1.2.1 Global Diagnostic Imaging Agent Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Conjugated Imaging Agent
  5. 1.2.3 Metabolic Imaging Agent
  6. 1.2.4 Blood Flow and Blood Volume Imaging Agents
  7. 1.3 Diagnostic Imaging Agent Market by Application
  8. 1.3.1 Global Diagnostic Imaging Agent Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Neurological Disease
  10. 1.3.3 Gastrointestinal Disease
  11. 1.3.4 Heart Disease
  12. 1.3.5 Tumor
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Diagnostic Imaging Agent Market Dynamics
  1. 2.1 Diagnostic Imaging Agent Industry Trends
  2. 2.2 Diagnostic Imaging Agent Industry Drivers
  3. 2.3 Diagnostic Imaging Agent Industry Opportunities and Challenges
  4. 2.4 Diagnostic Imaging Agent Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Diagnostic Imaging Agent Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Diagnostic Imaging Agent Revenue by Region
  3. 3.2.1 Global Diagnostic Imaging Agent Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Diagnostic Imaging Agent Revenue by Region (2021-2026)
  5. 3.2.3 Global Diagnostic Imaging Agent Revenue by Region (2027-2032)
  6. 3.2.4 Global Diagnostic Imaging Agent Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Diagnostic Imaging Agent Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Diagnostic Imaging Agent Sales by Region
  9. 3.4.1 Global Diagnostic Imaging Agent Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Diagnostic Imaging Agent Sales by Region (2021-2026)
  11. 3.4.3 Global Diagnostic Imaging Agent Sales by Region (2027-2032)
  12. 3.4.4 Global Diagnostic Imaging Agent Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Diagnostic Imaging Agent Revenue by Manufacturers
  2. 4.1.1 Global Diagnostic Imaging Agent Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Diagnostic Imaging Agent Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Diagnostic Imaging Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Diagnostic Imaging Agent Sales by Manufacturers
  6. 4.2.1 Global Diagnostic Imaging Agent Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Diagnostic Imaging Agent Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Diagnostic Imaging Agent Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Diagnostic Imaging Agent Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Diagnostic Imaging Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Diagnostic Imaging Agent Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Diagnostic Imaging Agent Manufacturers, Product Type & Application
  13. 4.7 Global Diagnostic Imaging Agent Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Diagnostic Imaging Agent Market CR5 and HHI
  16. 4.8.2 2025 Diagnostic Imaging Agent Tier 1, Tier 2, and Tier 3
5 Diagnostic Imaging Agent Market by Type
  1. 5.1 Global Diagnostic Imaging Agent Revenue by Type
  2. 5.1.1 Global Diagnostic Imaging Agent Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Diagnostic Imaging Agent Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Diagnostic Imaging Agent Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Diagnostic Imaging Agent Sales by Type
  6. 5.2.1 Global Diagnostic Imaging Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diagnostic Imaging Agent Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Diagnostic Imaging Agent Sales Market Share by Type (2021-2032)
  9. 5.3 Global Diagnostic Imaging Agent Price by Type
6 Diagnostic Imaging Agent Market by Application
  1. 6.1 Global Diagnostic Imaging Agent Revenue by Application
  2. 6.1.1 Global Diagnostic Imaging Agent Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Diagnostic Imaging Agent Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Diagnostic Imaging Agent Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Diagnostic Imaging Agent Sales by Application
  6. 6.2.1 Global Diagnostic Imaging Agent Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Diagnostic Imaging Agent Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Diagnostic Imaging Agent Sales Market Share by Application (2021-2032)
  9. 6.3 Global Diagnostic Imaging Agent Price by Application
7 Company Profiles
  1. 7.1 GE HealthCare
  2. 7.1.1 GE HealthCare Company Information
  3. 7.1.2 GE HealthCare Business Overview
  4. 7.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
  6. 7.1.5 GE HealthCare Recent Developments
  7. 7.2 Bracco Diagnostic
  8. 7.2.1 Bracco Diagnostic Company Information
  9. 7.2.2 Bracco Diagnostic Business Overview
  10. 7.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
  12. 7.2.5 Bracco Diagnostic Recent Developments
  13. 7.3 Guerbet
  14. 7.3.1 Guerbet Company Information
  15. 7.3.2 Guerbet Business Overview
  16. 7.3.3 Guerbet Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
  18. 7.3.5 Guerbet Recent Developments
  19. 7.4 Abx Advanced Biochemical
  20. 7.4.1 Abx Advanced Biochemical Company Information
  21. 7.4.2 Abx Advanced Biochemical Business Overview
  22. 7.4.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
  24. 7.4.5 Abx Advanced Biochemical Recent Developments
  25. 7.5 Bayer AG
  26. 7.5.1 Bayer AG Company Information
  27. 7.5.2 Bayer AG Business Overview
  28. 7.5.3 Bayer AG Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
  30. 7.5.5 Bayer AG Recent Developments
  31. 7.6 Blue Earth Diagnostics
  32. 7.6.1 Blue Earth Diagnostics Company Information
  33. 7.6.2 Blue Earth Diagnostics Business Overview
  34. 7.6.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
  36. 7.6.5 Blue Earth Diagnostics Recent Developments
  37. 7.7 Cardinal Health
  38. 7.7.1 Cardinal Health Company Information
  39. 7.7.2 Cardinal Health Business Overview
  40. 7.7.3 Cardinal Health Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
  42. 7.7.5 Cardinal Health Recent Developments
  43. 7.8 Eli Lilly and Company
  44. 7.8.1 Eli Lilly and Company Company Information
  45. 7.8.2 Eli Lilly and Company Business Overview
  46. 7.8.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
  48. 7.8.5 Eli Lilly and Company Recent Developments
  49. 7.9 Lantheus
  50. 7.9.1 Lantheus Company Information
  51. 7.9.2 Lantheus Business Overview
  52. 7.9.3 Lantheus Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Lantheus Diagnostic Imaging Agent Product Portfolio
  54. 7.9.5 Lantheus Recent Developments
  55. 7.10 Mallinckrodt
  56. 7.10.1 Mallinckrodt Company Information
  57. 7.10.2 Mallinckrodt Business Overview
  58. 7.10.3 Mallinckrodt Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
  60. 7.10.5 Mallinckrodt Recent Developments
  61. 7.11 Navidea
  62. 7.11.1 Navidea Company Information
  63. 7.11.2 Navidea Business Overview
  64. 7.11.3 Navidea Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Navidea Diagnostic Imaging Agent Product Portfolio
  66. 7.11.5 Navidea Recent Developments
  67. 7.12 Yantai Dongcheng
  68. 7.12.1 Yantai Dongcheng Company Information
  69. 7.12.2 Yantai Dongcheng Business Overview
  70. 7.12.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
  72. 7.12.5 Yantai Dongcheng Recent Developments
  73. 7.13 Foshan Rui Diao Pharmaceutical
  74. 7.13.1 Foshan Rui Diao Pharmaceutical Company Information
  75. 7.13.2 Foshan Rui Diao Pharmaceutical Business Overview
  76. 7.13.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
  78. 7.13.5 Foshan Rui Diao Pharmaceutical Recent Developments
  79. 7.14 Jubilant Pharma Limited
  80. 7.14.1 Jubilant Pharma Limited Company Information
  81. 7.14.2 Jubilant Pharma Limited Business Overview
  82. 7.14.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
  84. 7.14.5 Jubilant Pharma Limited Recent Developments
8 North America
  1. 8.1 North America Diagnostic Imaging Agent Market Size by Type
  2. 8.1.1 North America Diagnostic Imaging Agent Revenue by Type (2021-2032)
  3. 8.1.2 North America Diagnostic Imaging Agent Sales by Type (2021-2032)
  4. 8.1.3 North America Diagnostic Imaging Agent Price by Type (2021-2032)
  5. 8.2 North America Diagnostic Imaging Agent Market Size by Application
  6. 8.2.1 North America Diagnostic Imaging Agent Revenue by Application (2021-2032)
  7. 8.2.2 North America Diagnostic Imaging Agent Sales by Application (2021-2032)
  8. 8.2.3 North America Diagnostic Imaging Agent Price by Application (2021-2032)
  9. 8.3 North America Diagnostic Imaging Agent Market Size by Country
  10. 8.3.1 North America Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Diagnostic Imaging Agent Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Diagnostic Imaging Agent Market Size by Type
  2. 9.1.1 Europe Diagnostic Imaging Agent Revenue by Type (2021-2032)
  3. 9.1.2 Europe Diagnostic Imaging Agent Sales by Type (2021-2032)
  4. 9.1.3 Europe Diagnostic Imaging Agent Price by Type (2021-2032)
  5. 9.2 Europe Diagnostic Imaging Agent Market Size by Application
  6. 9.2.1 Europe Diagnostic Imaging Agent Revenue by Application (2021-2032)
  7. 9.2.2 Europe Diagnostic Imaging Agent Sales by Application (2021-2032)
  8. 9.2.3 Europe Diagnostic Imaging Agent Price by Application (2021-2032)
  9. 9.3 Europe Diagnostic Imaging Agent Market Size by Country
  10. 9.3.1 Europe Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Diagnostic Imaging Agent Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Diagnostic Imaging Agent Market Size by Type
  2. 10.1.1 China Diagnostic Imaging Agent Revenue by Type (2021-2032)
  3. 10.1.2 China Diagnostic Imaging Agent Sales by Type (2021-2032)
  4. 10.1.3 China Diagnostic Imaging Agent Price by Type (2021-2032)
  5. 10.2 China Diagnostic Imaging Agent Market Size by Application
  6. 10.2.1 China Diagnostic Imaging Agent Revenue by Application (2021-2032)
  7. 10.2.2 China Diagnostic Imaging Agent Sales by Application (2021-2032)
  8. 10.2.3 China Diagnostic Imaging Agent Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Diagnostic Imaging Agent Market Size by Type
  2. 11.1.1 Asia Diagnostic Imaging Agent Revenue by Type (2021-2032)
  3. 11.1.2 Asia Diagnostic Imaging Agent Sales by Type (2021-2032)
  4. 11.1.3 Asia Diagnostic Imaging Agent Price by Type (2021-2032)
  5. 11.2 Asia Diagnostic Imaging Agent Market Size by Application
  6. 11.2.1 Asia Diagnostic Imaging Agent Revenue by Application (2021-2032)
  7. 11.2.2 Asia Diagnostic Imaging Agent Sales by Application (2021-2032)
  8. 11.2.3 Asia Diagnostic Imaging Agent Price by Application (2021-2032)
  9. 11.3 Asia Diagnostic Imaging Agent Market Size by Country
  10. 11.3.1 Asia Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Diagnostic Imaging Agent Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Diagnostic Imaging Agent Market Size by Type
  2. 12.1.1 SAMEA Diagnostic Imaging Agent Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Diagnostic Imaging Agent Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Diagnostic Imaging Agent Price by Type (2021-2032)
  5. 12.2 SAMEA Diagnostic Imaging Agent Market Size by Application
  6. 12.2.1 SAMEA Diagnostic Imaging Agent Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Diagnostic Imaging Agent Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Diagnostic Imaging Agent Price by Application (2021-2032)
  9. 12.3 SAMEA Diagnostic Imaging Agent Market Size by Country
  10. 12.3.1 SAMEA Diagnostic Imaging Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Diagnostic Imaging Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Diagnostic Imaging Agent Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Diagnostic Imaging Agent Value Chain Analysis
  2. 13.1.1 Diagnostic Imaging Agent Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Diagnostic Imaging Agent Production Mode & Process
  6. 13.2 Diagnostic Imaging Agent Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Diagnostic Imaging Agent Distributors
  9. 13.2.3 Diagnostic Imaging Agent Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst